Alec Barclay, Chief Operations Officer at T2 Biosystems, Inc. (TTOO), bought 12,951 shares at $0.50 ($6K) on 2022-04-08, disclosed to the SEC on 2022-04-11.
Open-market purchase of $6k TTOO by Chief Operations Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| TTOO | SELL | 2020-02-25 | $5K | — | Filing → |
| TTOO | SELL | 2019-09-13 | $12K | — | Filing → |